Meshalkin Research Institute of Pathology of Circulation: Heart Diseases trials

The registry lists 12 Heart Diseases studies with Meshalkin Research Institute of Pathology of Circulation as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 2 2Phase 3 3No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• StEnt Coverage and Neointimal Tissue Characterization After eXtra Long evErolimus - Eluting Stent imPlantationStatus unknownNCT03401216Not applicable
• Acute Kidney Injury in Children After Cardiopulmonary BypassCompletedNCT03144011
• Epicardial Fat Pads Ablation During Coronary SurgeryStatus unknownNCT02984371Phase 2
• The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial FibrillationStatus unknownNCT02982434Phase 2
• Efficacy and Safety of Aspirin Therapy With CABGStatus unknownNCT02942680Phase 3
• Stress-MRI Assessment After Right Coronary Artery CTO RecanalizationCompletedNCT02769650Not applicable
• T-provisional Stenting vs Mini-Crush in Chronic Total Occlusions (CTO)CompletedNCT02708329Not applicable
• Sirolimus-eluting Stent CALYPSO vs Everolimus-eluting Stent XIENCECompletedNCT02681016Not applicable
• Surgical Prevention of Atrial Fibrillation in Patients With Rheumatic Mitral Valve Lesion and Left Atrium EnlargementCompletedNCT02474108Not applicable
• Normothermia Versus Hypothermia for Valvular Surgery PatientsCompletedNCT01338961Not applicable
• Study of Postoperative Nutritional Support in Cardiac Surgery.TerminatedNCT01312870Phase 3
• Omega 3 Fatty Acid Efficiency for Prevention of Atrial Fibrillation After Coronary Artery Bypass GraftingTerminatedNCT01175330Phase 3